Eliem Therapeutics Announces Pricing of Initial Public Offering
SEATTLE and CAMBRIDGE, United Kingdom, Aug. 09, 2021 (GLOBE NEWSWIRE) — Eliem Therapeutics, Inc., a…
Month: August 2021
atai Life Sciences to Host Conference Call and Webcast to Discuss Second Quarter 2021 Financial Results and Provide Business Update
BERLIN, Aug. 09, 2021 (GLOBE NEWSWIRE) — atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a…
CORRECTING and REPLACING – GoodRx and Boehringer Ingelheim Announce Joint Effort to Deliver Affordability Solutions to Patients
Potential to provide approximately $15 million a year in savings for life-enhancing medications SANTA MONICA,…
Bioasis Announces Allowance of Japanese Patent Application in Japan Relating to xB³™ Fusion Protein Comprising Iduronate-2-sulfatase
NEW HAVEN, Conn., Aug. 09, 2021 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the…
Cronos Group Inc. to Speak at the Canaccord Genuity 41st Annual Growth Conference
TORONTO, Aug. 09, 2021 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos…
Tonix Pharmaceuticals Reports Second Quarter 2021 Financial Results and Operational Highlights
Central Nervous System Pipeline Progressing with Two Phase 2 Studies (TNX-1300 and TNX-1900) and One…
Catalyst Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Corporate Update
-Q2 2021 Total Net Revenues of $36.4 Million Reflect Strong Quarter over Quarter Growth -Q2…
Monthly information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2021
Monthly information regarding the total number of voting rights and total number of shares of…
Medexus to Present at Canaccord Genuity’s 41st Annual Growth Conference
TORONTO and CHICAGO, Aug. 09, 2021 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”)…
Idera Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update
EXTON, Pa., Aug. 09, 2021 (GLOBE NEWSWIRE) — Idera Pharmaceuticals, Inc. (“Idera” or the “Company”)…
IGM Biosciences Announces Second Quarter 2021 Financial Results and Provides Corporate Update
– Recommended Phase 2 Dose of IGM-2323 Expected in 2021 – – Initial Data from…
Paratek Pharmaceuticals Announces Total Revenue of $57.5 Million in the Second Quarter 2021
— NUZYRA® (omadacycline) Generated Net U.S. Sales of $14.9 Million from the Core Commercial Business, a…
Vor Reports Second Quarter 2021 Financial Results and Provides Company Update
On track to report initial VOR33 clinical data in the first half of 2022 Announced…
AnaptysBio Announces Second Quarter 2021 Financial Results and Provides Pipeline Updates
Imsidolimab GPP GEMINI-1 Phase 3 trial anticipated to initiate in Q3 2021 following recent FDA end-of-Phase…
Design Therapeutics Reports GeneTAC™ Portfolio Progress and Second Quarter 2021 Results
Preclinical Data Support Initiation of Clinical Development of Lead GeneTAC Program for Friedreich Ataxia in…
NexImmune Reports Second Quarter 2021 Financial Results and Provides Business Updates
Announcing first solid tumor indication in HPV associated-malignancies – NEXI-003 Advancing two lead product candidates…
Recro Reports Second Quarter 2021 Financial Results
Q2 2021 Highlighted by Revenues of $18.0 Million, an Increase of 16% Compared to Q2…
Tricida Announces Second Quarter 2021 Financial Results
Webcast Today at 4:30 pm Eastern Time SOUTH SAN FRANCISCO, Calif., Aug. 09, 2021 (GLOBE…
Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2021 Financial Results
– SAD cohorts up to 640 mg and MAD cohorts up to 320 mg completed…
VistaGen Therapeutics to Report Fiscal Year 2022 First Quarter Financial Results and Host Conference Call and Webcast on August 12, 2021
SOUTH SAN FRANCISCO, Calif., Aug. 09, 2021 (GLOBE NEWSWIRE) — VistaGen Therapeutics, Inc. (NASDAQ: VTGN),…